Infectious bursal disease virus (IBDV) as a novel oncolytic virotherapy in glioblastoma.
Saved in:
| Title: | Infectious bursal disease virus (IBDV) as a novel oncolytic virotherapy in glioblastoma. |
|---|---|
| Authors: | Tur-Planells V; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.; Microbiology Section, Departamento de Ciencias Farmacéuticas y de la Salud, Facultad de Farmacia, Universidad San Pablo-CEU, CEU Universities, Madrid, Spain.; Department of Basic Medical Sciences, Facultad de Medicina, Instituto de Medicina Molecular Aplicada-Nemesio Díez (IMMA-ND), Universidad San Pablo-CEU, CEU Universities, Institute of Applied Molecular Medicine (IMMA), Madrid, Spain., Bykov Y; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Dawodu G; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA., García-Romero N; Faculty of Experimental Sciences, Universidad Francisco de Vitoria, Pozuelo de Alarcón, Community of Madrid, Spain., Izpura-Luis S; Microbiology Section, Departamento de Ciencias Farmacéuticas y de la Salud, Facultad de Farmacia, Universidad San Pablo-CEU, CEU Universities, Madrid, Spain.; Department of Basic Medical Sciences, Facultad de Medicina, Instituto de Medicina Molecular Aplicada-Nemesio Díez (IMMA-ND), Universidad San Pablo-CEU, CEU Universities, Institute of Applied Molecular Medicine (IMMA), Madrid, Spain., Pérez-Rodríguez L; Department of Oncological Science, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Rius-Rocabert S; Microbiology Section, Departamento de Ciencias Farmacéuticas y de la Salud, Facultad de Farmacia, Universidad San Pablo-CEU, CEU Universities, Madrid, Spain.; Department of Basic Medical Sciences, Facultad de Medicina, Instituto de Medicina Molecular Aplicada-Nemesio Díez (IMMA-ND), Universidad San Pablo-CEU, CEU Universities, Institute of Applied Molecular Medicine (IMMA), Madrid, Spain., Palacín-Aliana I; Department of Basic Medical Sciences, Facultad de Medicina, Instituto de Medicina Molecular Aplicada-Nemesio Díez (IMMA-ND), Universidad San Pablo-CEU, CEU Universities, Institute of Applied Molecular Medicine (IMMA), Madrid, Spain., Arranz-Herrero J; Microbiology Section, Departamento de Ciencias Farmacéuticas y de la Salud, Facultad de Farmacia, Universidad San Pablo-CEU, CEU Universities, Madrid, Spain.; Department of Basic Medical Sciences, Facultad de Medicina, Instituto de Medicina Molecular Aplicada-Nemesio Díez (IMMA-ND), Universidad San Pablo-CEU, CEU Universities, Institute of Applied Molecular Medicine (IMMA), Madrid, Spain.; National Center of Microbiology, Instituto de Salud Carlos III, Madrid, Community of Madrid, Spain., Márquez-Leiva I; National Center of Microbiology, Instituto de Salud Carlos III, Madrid, Community of Madrid, Spain., Monago-Sanchez A; Faculty of Experimental Sciences, Universidad Francisco de Vitoria, Pozuelo de Alarcón, Community of Madrid, Spain., Del Rio ML; Laboratorio de Inmunobiología de Trasplante e Inmunoterapia, Instituto de Biología Molecular (INBIOMIC), Universidad de León, León, Spain., Rodriguez-Barbosa JI; Laboratorio de Inmunobiología de Trasplante e Inmunoterapia, Instituto de Biología Molecular (INBIOMIC), Universidad de León, León, Spain., Cano-Ochando J; Department of Oncological Science, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; National Center of Microbiology, Instituto de Salud Carlos III, Madrid, Community of Madrid, Spain., García-Sastre A; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.; Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Department of Medicine, Division of Infectious Diseases, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Department of Pathology, Molecular and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; The Icahn Genomics Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Lozano-Ojalvo D; Centro de Investigación en ciencias de la alimentación CSIC-UAM, CIAL, Madrid, Community of Madrid, Spain., Nistal-Villan E; Microbiology Section, Departamento de Ciencias Farmacéuticas y de la Salud, Facultad de Farmacia, Universidad San Pablo-CEU, CEU Universities, Madrid, Spain sara.cuadrado@mssm.edu estanislao.nistalvillan@ceu.es ayusosa@vithas.es.; Department of Basic Medical Sciences, Facultad de Medicina, Instituto de Medicina Molecular Aplicada-Nemesio Díez (IMMA-ND), Universidad San Pablo-CEU, CEU Universities, Institute of Applied Molecular Medicine (IMMA), Madrid, Spain., Ayuso-Sacido A; Faculty of Experimental Sciences, Universidad Francisco de Vitoria, Pozuelo de Alarcón, Community of Madrid, Spain sara.cuadrado@mssm.edu estanislao.nistalvillan@ceu.es ayusosa@vithas.es.; Faculty of Medicine, Universidad Francisco de Vitoria, Madrid, Spain.; Brain Tumour Laboratory, Fundación Vithas, Grupo Hospitales Vithas, Madrid, Spain., Cuadrado-Castano S; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA sara.cuadrado@mssm.edu estanislao.nistalvillan@ceu.es ayusosa@vithas.es.; Department of Pathology, Molecular and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; The Icahn Genomics Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Marc and Jennifer Lipschultz Precision Immunology Institute (PrIISM), Icahn School of Medicine at Mount Sinai, New York, NY, USA. |
| Source: | Journal for immunotherapy of cancer [J Immunother Cancer] 2025 Nov 04; Vol. 13 (11). Date of Electronic Publication: 2025 Nov 04. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Electronic Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41193181 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Infectious bursal disease virus (IBDV) as a novel oncolytic virotherapy in glioblastoma. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Tur-Planells+V%22">Tur-Planells V</searchLink>; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.; Microbiology Section, Departamento de Ciencias Farmacéuticas y de la Salud, Facultad de Farmacia, Universidad San Pablo-CEU, CEU Universities, Madrid, Spain.; Department of Basic Medical Sciences, Facultad de Medicina, Instituto de Medicina Molecular Aplicada-Nemesio Díez (IMMA-ND), Universidad San Pablo-CEU, CEU Universities, Institute of Applied Molecular Medicine (IMMA), Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Bykov+Y%22">Bykov Y</searchLink>; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.<br /><searchLink fieldCode="AU" term="%22Dawodu+G%22">Dawodu G</searchLink>; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.<br /><searchLink fieldCode="AU" term="%22García-Romero+N%22">García-Romero N</searchLink>; Faculty of Experimental Sciences, Universidad Francisco de Vitoria, Pozuelo de Alarcón, Community of Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Izpura-Luis+S%22">Izpura-Luis S</searchLink>; Microbiology Section, Departamento de Ciencias Farmacéuticas y de la Salud, Facultad de Farmacia, Universidad San Pablo-CEU, CEU Universities, Madrid, Spain.; Department of Basic Medical Sciences, Facultad de Medicina, Instituto de Medicina Molecular Aplicada-Nemesio Díez (IMMA-ND), Universidad San Pablo-CEU, CEU Universities, Institute of Applied Molecular Medicine (IMMA), Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Pérez-Rodríguez+L%22">Pérez-Rodríguez L</searchLink>; Department of Oncological Science, Icahn School of Medicine at Mount Sinai, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Rius-Rocabert+S%22">Rius-Rocabert S</searchLink>; Microbiology Section, Departamento de Ciencias Farmacéuticas y de la Salud, Facultad de Farmacia, Universidad San Pablo-CEU, CEU Universities, Madrid, Spain.; Department of Basic Medical Sciences, Facultad de Medicina, Instituto de Medicina Molecular Aplicada-Nemesio Díez (IMMA-ND), Universidad San Pablo-CEU, CEU Universities, Institute of Applied Molecular Medicine (IMMA), Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Palacín-Aliana+I%22">Palacín-Aliana I</searchLink>; Department of Basic Medical Sciences, Facultad de Medicina, Instituto de Medicina Molecular Aplicada-Nemesio Díez (IMMA-ND), Universidad San Pablo-CEU, CEU Universities, Institute of Applied Molecular Medicine (IMMA), Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Arranz-Herrero+J%22">Arranz-Herrero J</searchLink>; Microbiology Section, Departamento de Ciencias Farmacéuticas y de la Salud, Facultad de Farmacia, Universidad San Pablo-CEU, CEU Universities, Madrid, Spain.; Department of Basic Medical Sciences, Facultad de Medicina, Instituto de Medicina Molecular Aplicada-Nemesio Díez (IMMA-ND), Universidad San Pablo-CEU, CEU Universities, Institute of Applied Molecular Medicine (IMMA), Madrid, Spain.; National Center of Microbiology, Instituto de Salud Carlos III, Madrid, Community of Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Márquez-Leiva+I%22">Márquez-Leiva I</searchLink>; National Center of Microbiology, Instituto de Salud Carlos III, Madrid, Community of Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Monago-Sanchez+A%22">Monago-Sanchez A</searchLink>; Faculty of Experimental Sciences, Universidad Francisco de Vitoria, Pozuelo de Alarcón, Community of Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Del+Rio+ML%22">Del Rio ML</searchLink>; Laboratorio de Inmunobiología de Trasplante e Inmunoterapia, Instituto de Biología Molecular (INBIOMIC), Universidad de León, León, Spain.<br /><searchLink fieldCode="AU" term="%22Rodriguez-Barbosa+JI%22">Rodriguez-Barbosa JI</searchLink>; Laboratorio de Inmunobiología de Trasplante e Inmunoterapia, Instituto de Biología Molecular (INBIOMIC), Universidad de León, León, Spain.<br /><searchLink fieldCode="AU" term="%22Cano-Ochando+J%22">Cano-Ochando J</searchLink>; Department of Oncological Science, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; National Center of Microbiology, Instituto de Salud Carlos III, Madrid, Community of Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22García-Sastre+A%22">García-Sastre A</searchLink>; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.; Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Department of Medicine, Division of Infectious Diseases, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Department of Pathology, Molecular and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; The Icahn Genomics Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Lozano-Ojalvo+D%22">Lozano-Ojalvo D</searchLink>; Centro de Investigación en ciencias de la alimentación CSIC-UAM, CIAL, Madrid, Community of Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Nistal-Villan+E%22">Nistal-Villan E</searchLink>; Microbiology Section, Departamento de Ciencias Farmacéuticas y de la Salud, Facultad de Farmacia, Universidad San Pablo-CEU, CEU Universities, Madrid, Spain sara.cuadrado@mssm.edu estanislao.nistalvillan@ceu.es ayusosa@vithas.es.; Department of Basic Medical Sciences, Facultad de Medicina, Instituto de Medicina Molecular Aplicada-Nemesio Díez (IMMA-ND), Universidad San Pablo-CEU, CEU Universities, Institute of Applied Molecular Medicine (IMMA), Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Ayuso-Sacido+A%22">Ayuso-Sacido A</searchLink>; Faculty of Experimental Sciences, Universidad Francisco de Vitoria, Pozuelo de Alarcón, Community of Madrid, Spain sara.cuadrado@mssm.edu estanislao.nistalvillan@ceu.es ayusosa@vithas.es.; Faculty of Medicine, Universidad Francisco de Vitoria, Madrid, Spain.; Brain Tumour Laboratory, Fundación Vithas, Grupo Hospitales Vithas, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Cuadrado-Castano+S%22">Cuadrado-Castano S</searchLink>; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA sara.cuadrado@mssm.edu estanislao.nistalvillan@ceu.es ayusosa@vithas.es.; Department of Pathology, Molecular and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; The Icahn Genomics Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Marc and Jennifer Lipschultz Precision Immunology Institute (PrIISM), Icahn School of Medicine at Mount Sinai, New York, NY, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101620585%22">Journal for immunotherapy of cancer</searchLink> [J Immunother Cancer] 2025 Nov 04; Vol. 13 (11). <i>Date of Electronic Publication: </i>2025 Nov 04. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BMJ+Publishing+Group+Ltd%22">BMJ Publishing Group Ltd </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101620585 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2051-1426 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220511426%22">20511426 </searchLink><i>NLM ISO Abbreviation: </i>J Immunother Cancer <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41193181 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1136/jitc-2025-011741 Languages: – Code: eng Text: English Titles: – TitleFull: Infectious bursal disease virus (IBDV) as a novel oncolytic virotherapy in glioblastoma. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Tur-Planells V – PersonEntity: Name: NameFull: Bykov Y – PersonEntity: Name: NameFull: Dawodu G – PersonEntity: Name: NameFull: García-Romero N – PersonEntity: Name: NameFull: Izpura-Luis S – PersonEntity: Name: NameFull: Pérez-Rodríguez L – PersonEntity: Name: NameFull: Rius-Rocabert S – PersonEntity: Name: NameFull: Palacín-Aliana I – PersonEntity: Name: NameFull: Arranz-Herrero J – PersonEntity: Name: NameFull: Márquez-Leiva I – PersonEntity: Name: NameFull: Monago-Sanchez A – PersonEntity: Name: NameFull: Del Rio ML – PersonEntity: Name: NameFull: Rodriguez-Barbosa JI – PersonEntity: Name: NameFull: Cano-Ochando J – PersonEntity: Name: NameFull: García-Sastre A – PersonEntity: Name: NameFull: Lozano-Ojalvo D – PersonEntity: Name: NameFull: Nistal-Villan E – PersonEntity: Name: NameFull: Ayuso-Sacido A – PersonEntity: Name: NameFull: Cuadrado-Castano S IsPartOfRelationships: – BibEntity: Dates: – D: 04 M: 11 Text: 2025 Nov 04 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 2051-1426 Numbering: – Type: volume Value: 13 – Type: issue Value: 11 Titles: – TitleFull: Journal for immunotherapy of cancer Type: main |
| ResultId | 1 |